Express Scripts Holding Co (NASDAQ:ESRX): Stock Big Money Are Happy About: at 0.69

May 16, 2018 - By Victoria Pittman

Express Scripts Holding Company (NASDAQ:ESRX) Corporate Logo

Express Scripts Holding Co’s Sentiment

“Big money sentiment for Express Scripts Holding Co (NASDAQ:ESRX) in 2017 Q4 increased to 0.69, according to SEC filings. So its up 0.06, from 2017Q3’s 0.63. 324 investment managers increased and started new stock positions, while 472 cut down and sold their positions in Express Scripts Holding Co so the sentiment improved. Funds own 479.26 million shares, down from 486.65 million shares in 2017Q3. Funds holding Express Scripts Holding Co in top 10 changed to 23 from 18 for an increase of 5. 68 Investors Sold All; 404 Reduced Holdings; 214 increased holdings while 110 investment managers bought holdings.

Biggest Express Scripts Holding Co Investors

Bloombergsen Inc. owns 2.65 million shares in Express Scripts Holding Co as of 2017 Q4. As of 2017 Q4, 3.55 million shares of Express Scripts Holding Co are owned by Green Valley Investors Llc. Cortland Associates Inc Mo reported 834,917 shares. The New York-based fund Chieftain Capital Management Inc. have invested about 9.21% of the investment professional’s stock portfolio in Express Scripts Holding Co. The United Kingdom-based fund Cedar Rock Capital Ltd looks positive on Express Scripts Holding Co, owning 4.88 million shares.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe.The firm is valued at $41.42 billion. It operates in two divisions, PBM and Other Business Operations.The P/E ratio is 9.53. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

ESRX is reaching $73.73 during the last trading session, after increased 0.67%.Currently Express Scripts Holding Company is uptrending after 8.93% change in last May 16, 2017. ESRX has 1.32M shares volume. The stock underperformed the S&P 500 by 2.62%.

Express Scripts Holding Company (NASDAQ:ESRX)’s earnings report is expected on July, 24., according to Zacks. Analysts forecast 29.48 % diference or $2.24 from the $1.73 EPS from 2017. This could be $1.26 billion profit for ESRX assuming the current $2.24 EPS will become reality. 26.55 % EPS growth is what analysts predict. $1.77 EPS was published for last quarter.

Employees Retirement Sys Of Texas has invested 0.12% in Express Scripts Holding Company (NASDAQ:ESRX). Virtus Investment Advisers accumulated 0.02% or 12,061 shs. Dowling Yahnke Ltd Liability Corporation accumulated 0.16% or 23,774 shs. Central Commercial Bank Trust invested in 0.03% or 1,481 shs. International Ca holds 0.02% of its capital in Express Scripts Holding Company (NASDAQ:ESRX) for 2,200 shs. First Quadrant Limited Partnership Ca holds 0.25% in Express Scripts Holding Company (NASDAQ:ESRX) or 178,354 shs. Verition Fund Mngmt Limited Liability reported 0.02% of its capital in Express Scripts Holding Company (NASDAQ:ESRX). Janney Montgomery Scott Ltd Liability has invested 0.11% in Express Scripts Holding Company (NASDAQ:ESRX). Mufg Americas reported 27,061 shs or 0.06% of all its holdings. Acadian Asset Mngmt Limited Liability Company reported 5,407 shs. Texas Permanent School Fund holds 154,615 shs or 0.14% of its capital. Boston Advisors Limited Liability reported 0.02% in Express Scripts Holding Company (NASDAQ:ESRX). Conning invested in 21,229 shs. Gemmer Asset Management Ltd Liability Corp owns 737 shs or 0.02% of their US capital. Amalgamated Bank & Trust reported 71,604 shs stake.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

Total analysts of 16 have positions in Express Scripts Holding (NASDAQ:ESRX) as follows: 5 rated it a “Buy”, 2 with “Sell” and 9 with “Hold”. The positive are 31%. Since December 4, 2017 according to StockzIntelligence Inc Express Scripts Holding has 28 analyst reports. In Wednesday, January 24 report Mizuho maintained the stock with “Hold” rating. On Thursday, March 29 the stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Hold” rating given by William Blair. On Thursday, May 3 the firm earned “Hold” rating by Leerink Swann. On Thursday, March 8 the rating was downgraded by Maxim Group to “Hold”. On Friday, December 15 the firm has “Outperform” rating given by Robert W. Baird. On Thursday, February 1 the firm earned “Underperform” rating by Bernstein. The company rating was maintained by Barclays Capital on Thursday, May 3. On Thursday, January 11 the stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Buy” rating by SunTrust. On Wednesday, December 20 SunTrust maintained Express Scripts Holding Company (NASDAQ:ESRX) with “Buy” rating. On Thursday, March 8 the rating was downgraded by Jefferies to “Hold”.

For more Express Scripts Holding Company (NASDAQ:ESRX) news released briefly go to: Streetinsider.com, Bizjournals.com, Nasdaq.com, Prnewswire.com or Gurufocus.com. The titles are as follows: “ValueAct’s 13F Shows New Stake in SLM Corp (SLM), Confirms Increase in Citi (C), Exits Microsoft (MSFT) (more…)” released on May 15, 2018, “Moody’s likes the upward financial trend at this Lakeland pharmacy benefits manager” on May 16, 2018, “Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck” with a publish date: May 11, 2018, “Inside Rx Prescription Savings Program Marks First Anniversary By Achieving $100 Million Savings Milestone” and the last “Merger Arbitrage Positions Dominate Seth Klarman’s Equity Portfolio” with publication date: May 16, 2018.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: